Trevi Therapeutics
TRVI
13.14
-0.04
-0.30%
Trevi Therapeutics
US · TRVI
#2810 by market cap
Listed 2019
13.14
-0.04
-0.30%
Live - 5344 symbols - heartbeat 60s ago
· 2026-10-08 08:20
Pre-market
13.09
-0.40%
After-hours
13.14
0.00%
- Market cap
- 1.87B
- P/E (TTM)i
- -37.54
- P/Bi
- 5.82
- EPSi
- -0.32
- Div yieldi
- 0.00%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on TRVI?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 10 analysts
Buy
Avg price target
29.00 +120.7%
Price target rangecurrent 13.14
Low23.00
Avg29.00
High40.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-21 | H.C. Wainwright | -- | BUY | 24.00 |
| 2026-08-13 | JonesTrading | -- | BUY | 28.00 |
| 2026-08-11 | H.C. Wainwright | -- | BUY | 24.00 |
| 2026-08-10 | Morgan Stanley | -- | BUY | 23.00 |
| 2026-08-07 | Raymond James | -- | BUY | 40.00 |
| 2026-08-07 | Morgan Stanley | -- | BUY | 23.00 |
| 2026-08-07 | Stifel | -- | BUY | 30.00 |
| 2026-08-07 | Needham | -- | BUY | 23.00 |
| 2026-08-07 | B. Riley Securities | -- | BUY | 31.00 |
| 2026-08-07 | Oppenheimer | -- | BUY | 25.00 |
| 2026-08-06 | Cantor Fitzgerald | -- | BUY | 30.00 |
| 2026-07-21 | BMO Capital | -- | BUY | 36.00 |
| 2026-07-20 | H.C. Wainwright | -- | BUY | 24.00 |
| 2026-07-17 | Morgan Stanley | -- | BUY | 20.00 |
| 2026-07-17 | Needham | -- | BUY | 23.00 |
| 2026-05-20 | Needham | -- | BUY | 23.00 |
| 2026-05-08 | Stifel | -- | BUY | 30.00 |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-05-08 | Oppenheimer | -- | BUY | 24.00 |
| 2026-05-07 | Clear Street | -- | BUY | 29.00 |
| 2026-05-06 | JonesTrading | -- | BUY | 24.00 |
| 2026-05-06 | Stifel | -- | BUY | 18.00 |
| 2026-05-06 | Needham | -- | BUY | 23.00 |
| 2026-05-06 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-05-05 | Morgan Stanley | -- | BUY | 20.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±13.26% | +0.05% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±8.34% | -2.73% (in line) |
| 2025/Q4 | 2026-03-17 | After close | ±13.85% | -4.47% (in line) |
| 2025/Q3 | 2025-11-13 | After close | ±11.94% | -0.79% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±12.96% | +1.64% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±14.41% | +0.00% (in line) |
| 2024/Q4 | 2025-03-18 | After close | ±15.34% | +3.81% (in line) |
| 2024/Q3 | 2024-11-06 | After close | -- | -6.45% |
| 2024/Q2 | 2024-08-08 | After close | -- | +2.14% |
| 2024/Q1 | 2024-05-07 | After close | ±37.93% | -8.97% (in line) |
| 2023/Q4 | 2024-03-20 | After close | -- | +4.52% |
| 2023/Q3 | 2023-11-09 | After close | -- | -3.32% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:20:29 · For reference only, not investment advice and not tailored to your situation.